Answers are grounded in this paper and cite their sources.
Despite growing concern about medical ghostwriting, pharmaceutical companies,, medical journals, and communication companies employing have thus far failed to adequately stem the problem. As a result, commentators have proposed that legal remedies could be sought by harmed by drugs publicized in ghostwritten papers. In this Essay, we build on a recent analysis by Stern and Lemmens in PLoS to outline specific areas of legal liability.
No takes yet. Share an insight, caveat, or question.
Bosch et al. (2012) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: